1Jakovljevic, M, Ostojic, L. Comorbidity and multimorbidity in medicine today: challenges and opportunities for bringing separated branches of medicine closer to each other. Psychiatr Danub 2013; 25(suppl 1): 18–28.
2Feinstein, AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis 1970; 23: 455–68.
3Ahern, TP, Horvath-Puho, E, Spindler, KL, Sorensen, HT, Ording, AG, Erichsen, R. Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort. Br J Cancer 2016; 114: 96–102.
4Alexander, M, Evans, SM, Stirling, RG, Wolfe, R, Officer, A, MacManus, M, et al. The influence of comorbidity and the simplified comorbidity score on overall survival in non-small cell lung cancer – a prospective cohort study. J Thorac Oncol 2016; 11: 748–57.
5Asano, T, Yamada, S, Fujii, T, et al. The Charlson age comorbidity index predicts prognosis in patients with resected pancreatic cancer. Int J Surg 2017; 39: 169–175.
6Baumeister, P, Rauch, J, Jacobi, C, et al. Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era. Head Neck 2017; 39: 7–16.
7Boehm, K, Dell'Oglio, P, Tian, Z, et al. Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancer. World J Urol 2016; 35: 1031–6.
8Corraini, P, Ording, AG, Henderson, VW, Szepligeti, S, Horvath-Puho, E, Sorensen, HT. Cancer, other comorbidity, and risk of venous thromboembolism after stroke: a population-based cohort study. Thromb Res 2016; 147: 88–93.
9Elshaikh, MA, Vance, S, Kamalignant, M, et al. Influence of comorbidity on the risk of death: a single institution study of 1132 women with early-stage uterine cancer. Am J Clin Oncol 2017; 40: 183–8.
10Gollnitz, I, Inhestern, J, Wendt, TG, et al. Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany. Cancer Med 2016; 5: 3260–71.
11Halvorsen, TO, Sundstrom, S, Flotten, O, et al. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer. Acta Oncol 2016; 55: 1349–54.
12Hiyoshi, A, Fall, K, Bergh, C, Montgomery, S. Comorbidity trajectories in working age cancer survivors: a national study of Swedish men. Cancer Epidemiol 2017; 48: 48–55.
13Ichikawa, H, Kosugi, SI, Kanda, T, et al. Surgical and long-term outcomes following oesophagectomy in oesophageal cancer patients with comorbidity. Int J Surg 2016; 36: 212–8.
14Kaul, S, Veeranki, SP, Rodriguez, AM, Kuo, YF. Cigarette smoking, comorbidity, and general health among survivors of adolescent and young adult cancer. Cancer 2016; 122: 2895–905.
15Chang, CM, Yin, WY, Wei, CK, et al. Correction: adjusted age-adjusted Charlson comorbidity index score as a risk measure of perioperative mortality before cancer surgery. PLoS One 2016; 11: e0157900.
16Froehner, M, Koch, R, Hubler, M, Wirth, MP. Validation of an age-adjusted prostate cancer-specific comorbidity index. Eur Urol 2016; 69: 764–6.
17Giugliano, FM, Falivene, S, Esposito, E, et al. Short-course radiotherapy in elderly women with breast cancer: comparison by age, comorbidity index and toxicity. Int J Surg 2016; 33(suppl 1): S92–6.
18Guldberg, TL, Christensen, S, Zachariae, R, Jensen, AB. Prognostic factors in early breast cancer associated with body mass index, physical functioning, physical activity, and comorbidity: data from a nationwide Danish cohort. Breast Cancer Res Treat 2017; 162: 159–67.
19Keshtgarpour, M, Tan, WS, Zwanziger, J, Awadalla, S, Langi, FG, Dudek, AZ. Prognostic value of serum proteomic test and comorbidity index in diversified population with lung cancer. Anticancer Res 2016; 36: 1759–65.
20Lee, JY, Kang, HW, Rha, KH et al. Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach. J Cancer Res Clin Oncol 2016; 142: 849–58.
21Noer, MC, Sperling, CD, Antonsen, SL, Ottesen, B, Christensen, IJ, Hogdall, C. A new clinically applicable age-specific comorbidity index for preoperative risk assessment of ovarian cancer patients. Gynecol Oncol 2016; 141: 471–8.
22Otake, S, Ohtsuka, T, Asakura, K, Kamiyama, I, Kohno, M. Impact of comorbidity index on morbidity and survival in non-small cell lung cancer. Asian Cardiovasc Thorac Ann 2016; 24: 30–3.
23Singh, N, Singh, PS, Aggarwal, AN, Behera, D. Comorbidity assessment using Charlson comorbidity index and simplified comorbidity score and its association with clinical outcomes during first-line chemotherapy for lung cancer. Clin Lung Cancer 2016; 17: 205–13.
24Tanaka, H, Takenaka, Y, Nakahara, S, et al. Age-adjusted Charlson comorbidity index as a prognostic factor of hypopharyngeal cancer treated with chemoradiation therapy. Acta Otolaryngol 2017; 137: 668–73.
25Tian, Y, Xu, B, Yu, G, Li, Y, Liu, H. Age-adjusted Charlson comorbidity index score as predictor of prolonged postoperative ileus in patients with colorectal cancer who underwent surgical resection. Oncotarget 2017; 8: 20794–801.
26Keszte, J, Danker, H, Dietz, A, et al. Course of psychiatric comorbidity and utilization of mental health care after laryngeal cancer: a prospective cohort study. Eur Arch Otorhinolaryngol 2017; 274: 1591–9.
27Ng, HS, Roder, D, Koczwara, B, Vitry, A. Comorbidity, physical and mental health among cancer patients and survivors: an Australian population-based study. Asia Pac J Clin Oncol 2017; DOI: 10.1111/ajco.12677.
28Faller, H, Weis, J, Koch, U, et al. Perceived need for psychosocial support depending on emotional distress and mental comorbidity in men and women with cancer. J Psychosom Res 2016; 81: 24–30.
29Nakash, O, Levav, I, Guilar-Gaxiola, S, et al. Comorbidity of common mental disorders with cancer and their treatment gap: findings from the World Mental Health Surveys. Psychooncology 2014; 23: 40–51.
30Lu, D, Andersson, TM, Fall, K, et al. Clinical diagnosis of mental disorders immediately before and after cancer diagnosis: a nationwide matched cohort study in Sweden. JAMA Oncol 2016; 2: 1188–96.
31Cawthorpe, D, Davidson, M. Temporal comorbidity of mental disorder and ulcerative colitis. Perm J 2015; 19: 52–7.
32Mantovani, A, Allavena, P, Sica, A, Balkwill, F. Cancer-related inflammation. Nature 2008; 454: 436–44.
33Coussens, LM, Werb, Z. Inflammation and cancer. Nature 2002; 420: 860–7.
34Mantovani, A, Marchesi, F, Porta, C, Sica, A, Allavena, P. Inflammation and cancer: breast cancer as a prototype. Breast 2007; 16(suppl 2): S27–33.
35Chiang, AC, Massague, J. Molecular basis of metastasis. N Engl J Med 2008; 359: 2814–23.
36Paul, B, Barnes, S, Mark-Wahnefried, W, et al. Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clin Epigenetics 2015; 7: 112.
37Alam, R, Abdolmaleky, HM, Zhou, JR. Microbiome, inflammation, epigenetic alterations, and mental diseases. Am J Med Genet B Neuropsychiatr Genet 2017; 174: 651–60.
38Batlle, E, Wilkinson, DG. Molecular mechanisms of cell segregation and boundary formation in development and tumorigenesis. Cold Spring Harb Perspect Biol 2012; 4: a008227.
39Zhu, J, Fang, F, Sjolander, A, Fall, K, Adami, HO, Valdimarsdottir, U. First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study. Ann Oncol 2017; 28: 1964–9.
40Trakhtenberg, EF, Goldberg, JL. The role of serotonin in axon and dendrite growth. Int Rev Neurobiol 2012; 106: 105–26.
41Kenis, C, Decoster, L, Bastin, J, et al. Functional decline in older patients with cancer receiving chemotherapy: a multicenter prospective study. J Geriatr Oncol 2017; 8: 196–205.
42Owusu, C, Margevicius, S, Schluchter, M, Koroukian, SM, Schmitz, KH, Berger, NA. Vulnerable elders survey and socioeconomic status predict functional decline and death among older women with newly diagnosed nonmetastatic breast cancer. Cancer 2016; 122: 2579–86.
43Granger, CL, McDonald, CF, Irving, L, et al. Low physical activity levels and functional decline in individuals with lung cancer. Lung Cancer 2014; 83: 292–9.
44Hoppe, S, Rainfray, M, Fonck, M, et al. Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol 2013; 31: 3877–82.
45Atlas, A, Grimmer, K, Kennedy, K. Early indications that low mental quality of life scores in recently unwell older people predict downstream functional decline. Clin Interv Aging 2015; 10: 703–12.
46Lee, Y. The predictive value of self assessed general, physical, and mental health on functional decline and mortality in older adults. J Epidemiol Community Health 2000; 54: 123–9.